ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Patients with locally advanced or metastatic lung cancer should receive treatment until disease ... 30mL of liquid should be administeredas per the naso-gastric tube manufacturer’s instructions with ... incidence of ILD was 10.9% in patients of Japanese ethnicity, 1.6% in patients of Asian ethnicity and 2.5% in non-Asian patients (see section ...
Tags:
Product, Summary, Characteristics, Cancer, Japanese, Gastric, Summary of product characteristics
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
Japanese classification of gastric carcinoma: 3rd English ...
www.jgca.jpJapanese Gastric Cancer Association (&) Association office, First Department of Surgery, Kyoto Prefectural University of Medicine, Kawaramachi, Kamigyo-ku, Kyoto 602-0841, Japan e-mail: jgca@koto.kpu-m.ac.jp 123 Gastric Cancer (2011) 14:101–112 DOI 10.1007/s10120-011-0041-5
Cancer, Japanese, Gastric, Gastric cancer, Japanese gastric cancer
Gastric Cancer Staging AJCC eighth edition
www.agps.org.auJapanese Gastric Cancer Association 2011 . Definitions – Distant metastases •M0 No distant metastasis •M1 Distant metastasis . Distant metastases •Liver •Peritoneum •Non-regional lymph nodes •Lung, CNS – less common •Direct extension into liver, colon, pancreas,
Cancer, Japanese, Gastric, Gastric cancer, Japanese gastric cancer
QOLに関するPatient Reported Outcomeの評価
archive.jsco.or.jpment. Lung Cancer 1995; 12:199-220. 12．Morita S, Kaptein AA, Oba K, Sakamoto J. The Domain Structure of the EORTC QLQ-STO22 Sup-ported by Japanese Validation Data. Psycho-Oncol-ogy 17: 474-9, 2008. 13．Eremenco SL, Cashy J, Webster K, Ohashi Y, Lock-er GY, Pelletier G, and Cella D. FACT-Gastric: A new international measure of QOL in gastric ...
Reported, Cancer, Japanese, Gastric, Qolに関するpatient reported outcomeの評価, Qolに関するpatient, Outcomeの評価
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
www.merck.comopioids for chronic non-cancer pain, although acausal relationship ... Monitor Japanese patients for gastrointestinal adverse reactions. (8.8) See 17 for PATIENT COUNSELING INFORMATION. ... 5.7 Risk of Serious Adverse Reactionsin Pancreatic and Gastric Anastomoses ENTEREG hasnot been studied in patients having pancreatic or gastric anastomosis ...
Information, Prescribing, Prescribing information, Cancer, Japanese, Gastric
Ultrasound Imaging System - University of California, Los ...
www.ccn.ucla.eduUltrasound used for sterilization of vaccines and for cancer therapy ! ... Used for arthritis, gastric ulcers, and eczema . History ! Post WWII ! Surplus Naval sonar equipment used for medical applications ! Based on radar and sonar techniques ! Japanese led the development of medical sonography in 1940s ! Pulse-echo measurements on ...
System, Imaging, Cancer, Ultrasound, Japanese, Gastric, Ultrasound imaging system
胃癌治療ガイドライン - jgca
www.jgca.jp胃癌治療ガイドラインの目的と対象 本ガイドラインは胃癌の日常診療に携わる医師を対象とし，1）胃癌の治療法について ...